相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response
Jorma J. de Ronde et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers
Rachael Natrajan et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer
Gottfried E. Konecny et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
Alexa B. Turke et al.
CANCER CELL (2010)
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Nicholas Turner et al.
CANCER RESEARCH (2010)
Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype
So Yeon Park et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas
Felipe C. Geyer et al.
JOURNAL OF PATHOLOGY (2010)
The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type
Britta Weigelt et al.
JOURNAL OF PATHOLOGY (2010)
Breast cancer molecular profiling with single sample predictors: a retrospective analysis
Britta Weigelt et al.
LANCET ONCOLOGY (2010)
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)
John M. S. Bartlett et al.
LANCET ONCOLOGY (2010)
Focal amplification and oncogene dependency of GAB2 in breast cancer
M. Bocanegra et al.
ONCOGENE (2010)
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
N. Turner et al.
ONCOGENE (2010)
EPIGENETICS AND GENETICS A census of amplified and overexpressed human cancer genes
Thomas Santarius et al.
NATURE REVIEWS CANCER (2010)
The pitfalls of platform comparison: DNA copy number array technologies assessed
Christina Curtis et al.
BMC GENOMICS (2009)
Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis
Britta Weigelt et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines
Alan Mackay et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor-Positive Breast Cancer
Robert J. Crowder et al.
CANCER RESEARCH (2009)
Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array
Fabrice Andre et al.
CLINICAL CANCER RESEARCH (2009)
Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers
Rachael Natrajan et al.
CLINICAL CANCER RESEARCH (2009)
Loss of 16q in High Grade Breast Cancer is Associated with Estrogen Receptor Status: Evidence for Progression in Tumors with a Luminal Phenotype?
Rachael Natrajan et al.
GENES CHROMOSOMES & CANCER (2009)
Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma
Felipe C. Geyer et al.
HISTOPATHOLOGY (2009)
Genetic characterization of breast cancer and implications for clinical management
Felipe C. Geyer et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Are HER2 and TOP2A Useful As Prognostic or Predictive Biomarkers for Anthracycline-Based Adjuvant Chemotherapy for Breast Cancer?
Kathleen I. Pritchard
JOURNAL OF CLINICAL ONCOLOGY (2009)
Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components
Caterina Marchio et al.
JOURNAL OF PATHOLOGY (2009)
Alterations in the TOP2A and HER2 Genes: Association With Adjuvant Anthracycline Sensitivity in Human Breast Cancers
Dennis J. Slamon et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum
Marick Lae et al.
MODERN PATHOLOGY (2009)
Transcriptome sequencing to detect gene fusions in cancer
Christopher A. Maher et al.
NATURE (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
Complex landscapes of somatic rearrangement in human breast cancer genomes
Philip J. Stephens et al.
NATURE (2009)
Histological and molecular types of breast cancer: is there a unifying taxonomy?
Britta Weigelt et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Mechanisms of change in gene copy number
P. J. Hastings et al.
NATURE REVIEWS GENETICS (2009)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer
G. Liu et al.
ONCOGENE (2009)
Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets
Elizabeth Iorns et al.
PLOS ONE (2009)
Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery
Jessica Kao et al.
PLOS ONE (2009)
Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
Marta Persson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Chimeric transcript discovery by paired-end transcriptome sequencing
Christopher A. Maher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: Further evidence to support the concept of low nuclear grade breast neoplasia family
Tarek M. A. Abdel-Fatah et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer
H. J. Burstein et al.
ANNALS OF ONCOLOGY (2008)
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
David Cameron et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer
Isabelle Bernard-Pierrot et al.
CANCER RESEARCH (2008)
Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer
Yuri Nikolsky et al.
CANCER RESEARCH (2008)
Subtypes of breast cancer show preferential site of relapse
Marcel Smid et al.
CANCER RESEARCH (2008)
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance
Elizabeth M. Swisher et al.
CANCER RESEARCH (2008)
Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast
Anne Vincent-Salomon et al.
CLINICAL CANCER RESEARCH (2008)
Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer
Mitch Dowsett et al.
CLINICAL CANCER RESEARCH (2008)
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2008)
Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia -: A comparative study of four differently designed, high resolution Microarray platforms
Rebeqa Gunnarsson et al.
GENES CHROMOSOMES & CANCER (2008)
DNA copy number alterations and expression of relevant genes in triple-negative breast cancer
Wonshik Han et al.
GENES CHROMOSOMES & CANCER (2008)
Is acinic cell carcinoma a variant of secretory carcinoma?: A FISH study using ETV6 'split apart' probes
J. S. Reis-Filho et al.
HISTOPATHOLOGY (2008)
How basal are triple-negative breast cancers?
Francois Bertucci et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Absence of ESR1 amplification in a series of breast cancers
Jose Adelaide et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
HER-2 and topoisomerase II as predictors of response to chemotherapy
Kathleen I. Pritchard et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Basal-like breast cancer: A critical review
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair
Alan Ashworth
JOURNAL OF CLINICAL ONCOLOGY (2008)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Refinement of breast cancer classification by molecular characterization of histological special types
B. Weigelt et al.
JOURNAL OF PATHOLOGY (2008)
Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast
C. Marchio et al.
JOURNAL OF PATHOLOGY (2008)
Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas
P. T. Simpson et al.
JOURNAL OF PATHOLOGY (2008)
ESR1 amplification in endometrial carcinomas: hope or hyperbole?
D. S. P. Tan et al.
JOURNAL OF PATHOLOGY (2008)
The genomic profile of HER2-amplified breast cancers: the influence of ER status
C. Marchio et al.
JOURNAL OF PATHOLOGY (2008)
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
Edurne Arriola et al.
LABORATORY INVESTIGATION (2008)
Resistance to therapy caused by intragenic deletion in BRCA2
Stacey L. Edwards et al.
NATURE (2008)
Accurate whole human genome sequencing using reversible terminator chemistry
David R. Bentley et al.
NATURE (2008)
ESR1 gene amplification in breast cancer:: a common phenomenon?
Anne Vincent-Salomon et al.
NATURE GENETICS (2008)
ESR1 gene amplification in breast cancer:: a common phenomenon?
Jorge S. Reis-Filho et al.
NATURE GENETICS (2008)
ESR1 gene amplification in breast cancer:: a common phenomenon?
Lindsay A. Brown et al.
NATURE GENETICS (2008)
ESR1 gene amplification in breast cancer:: a common phenomenon?
Hugo M. Horlings et al.
NATURE GENETICS (2008)
Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing
Peter J. Campbell et al.
NATURE GENETICS (2008)
Brk is coamplified with ErbB2 to promote proliferation in breast cancer
Bin Xiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes
L. Melchor et al.
ONCOGENE (2008)
CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome
Somaia Elsheikh et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D
S. Rayter et al.
ONCOGENE (2008)
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
David S. P. Tan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
Pratyaksha Wirapati et al.
BREAST CANCER RESEARCH (2008)
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
Berengere Marty et al.
BREAST CANCER RESEARCH (2008)
Integrated profiling of basal and luminal breast cancers
Jose Adelaide et al.
CANCER RESEARCH (2007)
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin® are most likely to benefit from trastuzumab-based therapy:: an hypothesis-generating study
A. Sapino et al.
ANNALS OF ONCOLOGY (2007)
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer
Edurne Arriola et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Amplification of CCND1 and PAK1 as predictors of recurrence and tamoxifen resistance in postmenopausal breast cancer
J. Bostner et al.
ONCOGENE (2007)
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer:: BIG 1-98
Giuseppe Viale et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research
David S. P. Tan et al.
LABORATORY INVESTIGATION (2007)
EGFR associated expression profiles vary with breast tumor subtype
Katherine A. Hoadley et al.
BMC GENOMICS (2007)
Utilizing RNA interference to enhance cancer drug discovery
Elizabeth Iorns et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Trastuzumab: triumphs and tribulations
R. Nahta et al.
ONCOGENE (2007)
Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer
Frederik Holst et al.
NATURE GENETICS (2007)
Resolving the resolution of array CGH
Bradley P. Coe et al.
GENOMICS (2007)
High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer
J. Parssinen et al.
BRITISH JOURNAL OF CANCER (2007)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers
S-F Chin et al.
ONCOGENE (2007)
BRCA1 dysfunction in sporadic basal-like breast cancer
N. C. Turner et al.
ONCOGENE (2007)
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
Suet F. Chin et al.
GENOME BIOLOGY (2007)
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
Jason I. Herschkowitz et al.
GENOME BIOLOGY (2007)
Genome position and gene amplification
Pavla Gajduskova et al.
GENOME BIOLOGY (2007)
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer
G. Valabrega et al.
ANNALS OF ONCOLOGY (2007)
Are triple-negative tumours and basal-like breast cancer synonymous?
Emad A. Rakha et al.
BREAST CANCER RESEARCH (2007)
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
Bas Kreike et al.
BREAST CANCER RESEARCH (2007)
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
Somaia Elbauomy Elsheikh et al.
BREAST CANCER RESEARCH (2007)
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival
Laura G. Fulford et al.
BREAST CANCER RESEARCH (2007)
High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma
Tarek M. A. Abdel-Fatah et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer
Zeng Quan Yang et al.
CANCER RESEARCH (2006)
Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance
Emad A. Rakha et al.
EUROPEAN JOURNAL OF CANCER (2006)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells
Robin L. Kilker et al.
CANCER RESEARCH (2006)
Novel patterns of genome rearrangement and their association with survival in breast cancer
James Hicks et al.
GENOME RESEARCH (2006)
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Koei Chin et al.
CANCER CELL (2006)
FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas
Jorge Sergio Reis-Filho et al.
CLINICAL CANCER RESEARCH (2006)
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer
Anna Bergamaschi et al.
GENES CHROMOSOMES & CANCER (2006)
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis
Patrick W. B. Derksen et al.
CANCER CELL (2006)
A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH
R. Roylance et al.
ONCOGENE (2006)
Basal-like breast cancer and the BRCA1 phenotype
N. C. Turner et al.
ONCOGENE (2006)
Molecular classification of breast cancer: Limitations and potential
Lajos Pusztai et al.
ONCOLOGIST (2006)
EGFR amplification and lack of activating mutations in metaplastic breast carcinomas
J. S. Reis et al.
JOURNAL OF PATHOLOGY (2006)
RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes
Jessica Kao et al.
GENES CHROMOSOMES & CANCER (2006)
Gene amplification in cancer
Donna G. Albertson
TRENDS IN GENETICS (2006)
Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas:: an immunohistochemical and chromogenic in situ hybridisation analysis
Jorge S. Reis-Filho et al.
MODERN PATHOLOGY (2006)
Topoisomerase IIα gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer:: Scandinavian Breast Group Trial 9401
Minna Tanner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
A. S. Doane et al.
ONCOGENE (2006)
Intermingling of chromosome territories in interphase suggests role in translocations and transcription-dependent associations
Miguel R. Branco et al.
PLOS BIOLOGY (2006)
The molecular portraits of breast tumors are conserved across microarray platforms
Zhiyuan Hu et al.
BMC GENOMICS (2006)
Breast tumor copy number aberration phenotypes and genomic instability
J Fridlyand et al.
BMC CANCER (2006)
Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Comprehensive profiling of 8p11-12 amplification in breast cancer
W Gelsi-Boyer et al.
MOLECULAR CANCER RESEARCH (2005)
NRG1 gene rearrangements in clinical breast cancer:: identification of an adjacent novel amplicon associated with poor prognosis
LM Prentice et al.
ONCOGENE (2005)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer
EH Romond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer
T Takano et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
EGFR gene amplification in breast cancer:: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
R Bhargava et al.
MODERN PATHOLOGY (2005)
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
SR Lakhani et al.
CLINICAL CANCER RESEARCH (2005)
Identification of molecular apocrine breast tumours by microarray analysis
P Farmer et al.
ONCOGENE (2005)
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
M Moroni et al.
LANCET ONCOLOGY (2005)
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
JS Reis et al.
BREAST CANCER RESEARCH (2005)
Gene copy mapping of the ERBB2/TOP2A region in breast cancer
KK Jacobson et al.
GENES CHROMOSOMES & CANCER (2004)
Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes
B Orsetti et al.
CANCER RESEARCH (2004)
Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics
M Lacroix et al.
ENDOCRINE-RELATED CANCER (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Prognostic relevance of gene amplifications and coamplifications in breast cancer
K Al-Kuraya et al.
CANCER RESEARCH (2004)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cyclin D1, EMS1 and 11q13 amplification in breast cancer
CJ Ormandy et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma
C Tognon et al.
CANCER CELL (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution
H Buerger et al.
JOURNAL OF PATHOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
